Health And Medicine

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications. Read More

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders. Read More

An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered. Read More

Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease. Read More

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence. Read More

Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers. Read More

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies. Read More

Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders. Read More

Vanderbilt University’s Cyndya Shibao, M.D., MSCI, has received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation. Read More

Vanderbilt University researchers have received a five-year, $1.2 million grant from the Fogarty International Center of the National Institutes of Health (NIH) to strengthen research ethics capacity in Mozambique. Read More

Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Read More

The protein MTBP is overexpressed in an aggressive type of breast cancer, and it regulates another protein implicated in many cancer types, suggesting that it may be a good target for new therapeutics. Read More

The fungicide amphotericin B may be a useful treatment for a frog fungus that is killing amphibians worldwide. Read More

Researchers at Vanderbilt University, the University of Arizona and Phoenix Children’s Hospital have discovered what triggers a rare but devastating diarrheal disease in newborns that is fatal without intravenous feeding or intestinal transplant. Read More

A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online this week in Nature Genetics. Read More

Registered nurses are staying in the workforce longer than in past decades, boosting the nation’s supply of R.N.s, according to a new study whose authors include Vanderbilt University Medical Center’s Peter Buerhaus, Ph.D. Read More

Vanderbilt University’s Satish Raj, M.D., MSCI, was very busy — and very visible — at the Dysautonomia International Conference in Washington, D.C., earlier this month. Read More

A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer. Read More

Understanding how the immune system responds to the respiratory virus HMPV is crucial for developing vaccines and anti-viral treatments. Read More

Augmenting the signals of natural “endocannabinoids” in the brain may be a promising approach for treating mood and anxiety disorders. Read More